Massol J, Martin P, Soubrié P, Simon P
Eur J Pharmacol. 1987 Feb 24;134(3):345-8. doi: 10.1016/0014-2999(87)90367-0.
Triiodothyronine (T3), successfully used as therapeutic agent in euthyroid depressive states, has been found to exert an antidepressant-like effect in various psychopharmacological tests in rodents. Therefore the possible antidepressant-like activity of triiodothyroacetic acid (TA3), a natural metabolite of T3, was investigated in rats subjected to helplessness training. The animals were first exposed to inescapable shock pretreatment (60 shocks, 15 s duration, 0.8 mA every min +/- 15 s) and 48 h later, shuttle-box training (30 trials/day, ITI: 30 s) was performed on 3 consecutive days in order to assess escape deficits. As compared to control rats (no shock pretreatment), the rats exposed to inescapable shocks exhibited escape deficits when tested for subsequent responding in the shuttle-box. Daily i.p. injections of TA3 (0.5 mg/kg) prevented escape deficits as did daily injections of tricyclic antidepressants. These data are in agreement with previous results bearing on the similarity of action of TA3 and tricyclic antidepressants and extend to the thyroid axis the neuroendocrine systems that can be affected by exposure to uncontrollable stressors.
三碘甲状腺原氨酸(T3)已成功用作甲状腺功能正常的抑郁状态的治疗药物,并且发现在啮齿动物的各种心理药理学测试中具有抗抑郁样作用。因此,在接受无助训练的大鼠中研究了T3的天然代谢产物三碘甲状腺乙酸(TA3)可能具有的抗抑郁样活性。首先让动物接受不可逃避的休克预处理(60次电击,持续15秒,每分钟0.8毫安±15秒),48小时后,连续3天进行穿梭箱训练(每天30次试验,间隔时间:30秒),以评估逃避缺陷。与对照大鼠(无休克预处理)相比,接受不可逃避电击的大鼠在穿梭箱中进行后续反应测试时表现出逃避缺陷。每天腹腔注射TA3(0.5毫克/千克)可预防逃避缺陷,每天注射三环类抗抑郁药也有同样效果。这些数据与之前关于TA3和三环类抗抑郁药作用相似性的结果一致,并将可受暴露于不可控应激源影响的神经内分泌系统扩展到了甲状腺轴。